Overview

Antioxidant Micronutrients in Malaria

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
In the last decade, the prevalence of malaria has been escalating at an alarming rate, especially in Africa. An estimated 300 to 500 million cases each year cause 1.5 to 2.7 million deaths, more than 90% occur in children under 5 years of age in Africa (WHO 1995). Malaria is Africa's leading cause of under-five mortality (20%) and constitutes 10% of the continent's overall disease burden. It accounts for 40% of public health expenditure, 30-50% of inpatient admissions, and up to 50% of outpatient visits in areas with high malaria transmission. Antioxidant micronutrients have immunomodulatory role and may have suppressive activity.
Phase:
Phase 3
Details
Lead Sponsor:
University of Lagos, Nigeria
Treatments:
alpha-Tocopherol
Amodiaquine
Amodiaquine, artesunate drug combination
Antioxidants
Artemether
Artemisinins
Artesunate
Lumefantrine
Micronutrients
Retinol palmitate
Selenium
Tocopherols
Tocotrienols
Trace Elements
Vitamin A
Vitamin E
Vitamins
Zinc